The Trentino region is strengthening its international presence in the life sciences sector through a targeted mission in the United States, aimed at building partnerships and attracting investment. The initiative highlights a distinctly Italian model that integrates research, industry, and public institutions into a coordinated ecosystem.
A delegation including representatives from the Autonomous Province of Trento, Trentino Sviluppo, the University of Trento, and biotech firms is presenting the region as an innovation hub with strong scientific capabilities. The main event took place in New York on April 15, where Trentino showcased its life sciences platform and explored collaboration opportunities with American stakeholders.
The mission also includes stops in Boston and Houston. In Boston, the focus is on engaging with leading research institutions and biotech companies, while in Houston meetings emphasize broader cooperation, including connections with major medical and research centers. These interactions allow Trentino to compare its model with global leaders and expand its international network.
The region already employs around 5,000 researchers and generates approximately €683 million in annual trade with the United States. Strengthening the life sciences cluster is expected to boost both investment and high-value exports.
Trentino’s strategy combines scientific excellence with quality of life and cost competitiveness. Compared to U.S. standards, it offers advanced research capabilities at lower costs, making it attractive for partnerships. At the same time, its focus on sustainability and livability appeals to global talent.
Overall, the mission reflects a broader shift in which Italian regions are becoming more active players in global innovation, positioning themselves as reliable partners in research and technology development.
